Lexicon Pharmaceuticals Inc (LXRX)
0.8634
+0.09
(+11.88%)
USD |
NASDAQ |
Nov 22, 16:00
0.8755
+0.01
(+1.40%)
After-Hours: 20:00
Lexicon Pharmaceuticals Cash from Operations (Quarterly): -53.62M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -53.62M |
| June 30, 2024 | -48.54M |
| March 31, 2024 | -55.13M |
| December 31, 2023 | -50.55M |
| September 30, 2023 | -41.62M |
| June 30, 2023 | -38.12M |
| March 31, 2023 | -31.61M |
| December 31, 2022 | -21.57M |
| September 30, 2022 | -19.44M |
| June 30, 2022 | -24.42M |
| March 31, 2022 | -23.42M |
| December 31, 2021 | -22.83M |
| September 30, 2021 | -17.15M |
| June 30, 2021 | -21.88M |
| March 31, 2021 | -25.16M |
| December 31, 2020 | -34.24M |
| September 30, 2020 | -40.38M |
| June 30, 2020 | -46.30M |
| March 31, 2020 | -22.05M |
| December 31, 2019 | -24.37M |
| September 30, 2019 | 190.70M |
| June 30, 2019 | -26.90M |
| March 31, 2019 | -25.62M |
| December 31, 2018 | -27.13M |
| September 30, 2018 | -22.18M |
| Date | Value |
|---|---|
| June 30, 2018 | -52.52M |
| March 31, 2018 | -46.78M |
| December 31, 2017 | -33.71M |
| September 30, 2017 | -33.96M |
| June 30, 2017 | -32.22M |
| March 31, 2017 | -85.50M |
| December 31, 2016 | -48.79M |
| September 30, 2016 | -35.22M |
| June 30, 2016 | -47.88M |
| March 31, 2016 | -43.74M |
| December 31, 2015 | 265.92M |
| September 30, 2015 | -25.48M |
| June 30, 2015 | -32.18M |
| March 31, 2015 | -23.48M |
| December 31, 2014 | -4.458M |
| September 30, 2014 | -21.19M |
| June 30, 2014 | -19.66M |
| March 31, 2014 | -30.32M |
| December 31, 2013 | -21.74M |
| September 30, 2013 | -23.94M |
| June 30, 2013 | -21.13M |
| March 31, 2013 | -24.27M |
| December 31, 2012 | -20.43M |
| September 30, 2012 | -25.07M |
| June 30, 2012 | -21.96M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-55.13M
Minimum
Mar 2024
-17.15M
Maximum
Sep 2021
-33.12M
Average
-28.39M
Median
Cash from Operations (Quarterly) Benchmarks
| Viatris Inc | 826.50M |
| Halozyme Therapeutics Inc | 115.38M |
| Perspective Therapeutics Inc | 3.366M |
| Quanterix Corp | -4.951M |
| Autonomix Medical Inc | -1.596M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 53.47M |
| Cash from Financing (Quarterly) | -0.916M |
| Free Cash Flow | -208.39M |
| Free Cash Flow Per Share (Quarterly) | -0.1492 |
| Free Cash Flow to Equity (Quarterly) | -54.32M |
| Free Cash Flow Yield | -83.02% |